Wednesday, June 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “modified”

433 pharma patents match "modified" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 433
Index total 30,257
Page 3 / 19

Quick answer

This filtered view shows 433 pharmaceutical patents matching "modified" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

433 results for “modified” · 30,257 patents in full index Clear search

  1. US 11778995

    Genetically modified non-human animals and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  2. US 11766032

    Genetically modified non-human animals expressing human EPO

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 26, 2023 · Expires Sep 21, 2043

    granted

  3. US 11739162

    Side chain modified peptoids useful as structure-stabilizing coatings for biomaterials

    The Regents of the University of California · Granted Aug 29, 2023 · Expires Aug 24, 2043

    granted

  4. US 11684572

    Methods for producing carboxylate ligand modified ferric iron hydroxide colloids and related compositions and uses

    United Kingdom Research and Innovation · Granted Jun 27, 2023 · Expires Jun 22, 2043

    granted

  5. US 11633488

    Modified IL-2 polypeptides and uses thereof

    Bright Peak Therapeutics AG · Granted Apr 25, 2023 · Expires Apr 20, 2043

    granted

  6. US 11629348

    Linkage modified oligomeric compounds and uses thereof

    Ionis Pharmaceuticals, Inc. · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  7. US 11622547

    Genetically modified mouse that expresses human albumin

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 11, 2023 · Expires Apr 6, 2043

    granted

  8. US 11613744

    Modified urokinase-type plasminogen activator polypeptides and methods of use

    Vertex Pharmaceuticals Incorporated · Granted Mar 28, 2023 · Expires Mar 23, 2043

    granted

  9. US 11603392

    Vault particles having a modified R8 flexible region

    The Regents of the University of California · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted

  10. US 11597853

    Coatings containing polymer modified enzyme for stable self-cleaning of organic stains

    Regents of the University of Minnesota · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted

  11. US 11583556

    Modified cells and methods of therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 21, 2023 · Expires Feb 16, 2043

    granted

  12. US 11576984

    Genetically modified mouse with humanized immunoglobulin heavy chain constant region genes and method of using

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted

  13. US 11576356

    Genetically modified non-human animals and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted

  14. US 11566149

    Coatings containing polymer modified enzyme for stable self-cleaning of organic stains

    Regents of the University of Minnesota · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted

  15. AU 2021290177

    A recombinant Modified Vaccinia Virus Ankara (MVA) vaccine against coronavirus disease

    BAVARIAN NORDIC AS [DK] · Granted Jan 19, 2023 · Expires Jan 14, 2043

    granted

  16. US 11549109

    Modified double-stranded RNA agents

    Alnylam Pharmaceuticals, Inc. · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  17. US 11548852

    Modified amino acids

    Sutro Biopharma, Inc. · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  18. US 11549110

    Modified short interfering nucleic acid (siNA) molecules and uses thereof

    Aligos Therapeutics, Inc. · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  19. US 11535870

    Adeno-associated virus vectors encoding modified G6PC and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted

  20. US 11535773

    Coatings containing polymer modified enzyme for stable self-cleaning of organic stains

    Regents of the University of Minnesota · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted

  21. US 11504391

    Modified RNA agents with reduced off-target effect

    Alnylam Pharmaceuticals, Inc. · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted

  22. US 11491212

    Subcutaneous administration of modified factor IX polypeptides and treatment of hemophilia B

    Catalyst Biosciences, Inc. · Granted Nov 8, 2022 · Expires Nov 3, 2042

    granted

  23. US 11466274

    Modified gapmer oligonucleotides and methods of use

    Aligos Therapeutics, Inc. · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  24. US 11453861

    Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)

    Precision BioSciences, Inc. · Granted Sep 27, 2022 · Expires Sep 22, 2042

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.